The PubMed entry describes a 2026 research article published in Gut Microbes: “Gut microbiota and metabolic alterations in participants with flatulence identify Faecalibacterium prausnitzii as a key microbial target for clinical intervention.” The citation is Ruimin Chen et al., Gut Microbes. 2026;18(1):2728332. The DOI is 10.1080/19490976.2026.2728332 and the PubMed ID (PMID) is 42689867. The article was made available online (Epub) on 3 September 2026 according to the bibliographic metadata provided in the record.
Authors listed on the PubMed record are affiliated with Jiangnan University (State Key Laboratory of Food Science and Resources; School of Food Science and Technology), the Department of Gastroenterology at the Affiliated Hospital of Jiangnan University, and the National Engineering Research Center for Functional Food. The PubMed entry is indexed with the publication type “Randomized Controlled Trial.”
The article title identifies Faecalibacterium prausnitzii as a key microbial target associated with gut microbiota and metabolic alterations in participants reporting flatulence. This framing indicates that the authors observed microbiome and metabolic differences linked to the symptom of flatulence and singled out F. prausnitzii as noteworthy for potential clinical intervention.
The provided PubMed excerpt contains only the title and bibliographic metadata; it does not include the abstract, figures, tables, or results. Therefore, while the title reports the association and proposes F. prausnitzii as a target, the supporting data, analytic methods, effect sizes, statistical significance, and specific metabolic markers are not available in the supplied source text and are not summarized here.
The record labels the work as a Randomized Controlled Trial, but the PubMed extract shown does not include the trial design details. Key elements commonly required to assess a clinical trial—sample size, inclusion/exclusion criteria, randomization method, intervention details, comparator, primary and secondary endpoints, statistical analysis plan, and adverse event reporting—are not present in the provided content. As such, those methodological and outcome data were not reported in the source available here and cannot be restated.
Users seeking to evaluate the validity, magnitude, and clinical applicability of the title’s claim should consult the full published article or its abstract on the publisher’s site or PubMed to access the complete methods and results.
Based strictly on the information available in the PubMed record:
The work highlights a potential link between the gut microbiota, metabolic alterations, and symptomatic flatulence, with Faecalibacterium prausnitzii proposed as a microbial target for clinical intervention.
Because the detailed evidence is not present in this source excerpt, clinicians and researchers should review the full article before drawing conclusions or altering practice. The full text is needed to determine whether the finding arose from observational microbiome comparisons, mechanistic metabolic profiling, or an interventional trial that manipulated microbial composition.
If the full article confirms robust, clinically meaningful effects, follow-up steps could include replication in independent cohorts, mechanistic studies to define how F. prausnitzii relates to gas production or host metabolism, and carefully designed interventional trials to test safety and efficacy of targeting this species. However, these steps are suggested as general next actions and are not described in the PubMed excerpt itself.
To evaluate and apply the findings responsibly, obtain the complete article via the DOI (10.1080/19490976.2026.2728332) or through the Gut Microbes journal. The PubMed record provides authorship, affiliations, DOI, PMID, and the journal citation but does not include the abstract or primary data in the excerpt provided here. Accessing the full manuscript will supply the methodological specifics, numerical results, and the authors’ discussion and conclusions.
Note: This rewritten summary preserves the information present in the PubMed entry and does not infer or invent methodological details, numerical results, or clinical recommendations that were not included in the provided source text.